Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anna Sureda

Showing results (21-30 of 380) with videos related to

Pageof 38
Sort By:
Critical Reviews in Oncology/Hematology|May 17, 2019
Neutropenia during frontline treatment of advanced Hodgkin lymphoma: Incidence, risk factors, and managementAnna Sureda, Eva Domingo-Domenech, Ashish Gautam
British Journal of Haematology|August 20, 2008
Allogeneic transplantation for Hodgkin lymphomaKarl S Peggs, Paolo Anderlini, Anna Sureda
Medicina Clinica|December 5, 2016
Update on diagnosis and treatment of adult T-cell leukaemia/lymphomaSantiago Mercadal, Anna Sureda, Eva González-Barca
Current Treatment Options in Oncology|April 23, 2014
The role of allogeneic stem cell transplantation in Hodgkin's lymphomaAnna Sureda, E Domenech, N Schmitz, et al.
Current Opinion in Oncology|October 20, 2012
The role of hematopoietic stem cell transplantation in the treatment of relapsed/refractory Hodgkin's lymphomaAnna Sureda, Maria I Barbosa Pereira, Peter Dreger, et al.
Frontiers in Immunology|August 25, 2022
Editorial: Novel treatments for diffuse large B-cell lymphoma: The post-CART eraAlberto Mussetti, Enrico Derenzini, Sarkozy Clementine, et al.
Blood|December 8, 2009
Allogeneic transplantation for children and adolescents with Hodgkin lymphomaNorbert Schmitz, Anna Sureda, Giorgio Dini, et al.
Haematologica|November 21, 2007
Allogeneic transplantation in lymphoma: current statusNorbert Schmitz, Peter Dreger, Bertram Glass, et al.
Leukemia & Lymphoma|May 13, 2022
Novel strategies for relapsed/refractory DLBCL; navigating the immunotherapy era in aggressive lymphomaMax J Gordon, Anna Sureda, Jason R Westin
Journal of Clinical Medicine|August 27, 2021
Is Post-Transplant Cyclophosphamide the New Methotrexate?Alberto Mussetti, Annalisa Paviglianiti, Rocio Parody, et al.
Pageof 38

Showing results (21-30 of 380) with videos related to

Sort By:
Pageof 38
Critical Reviews in Oncology/Hematology|May 17, 2019
Neutropenia during frontline treatment of advanced Hodgkin lymphoma: Incidence, risk factors, and managementAnna Sureda, Eva Domingo-Domenech, Ashish Gautam
British Journal of Haematology|August 20, 2008
Allogeneic transplantation for Hodgkin lymphomaKarl S Peggs, Paolo Anderlini, Anna Sureda
Medicina Clinica|December 5, 2016
Update on diagnosis and treatment of adult T-cell leukaemia/lymphomaSantiago Mercadal, Anna Sureda, Eva González-Barca
Current Treatment Options in Oncology|April 23, 2014
The role of allogeneic stem cell transplantation in Hodgkin's lymphomaAnna Sureda, E Domenech, N Schmitz, et al.
Current Opinion in Oncology|October 20, 2012
The role of hematopoietic stem cell transplantation in the treatment of relapsed/refractory Hodgkin's lymphomaAnna Sureda, Maria I Barbosa Pereira, Peter Dreger, et al.
Frontiers in Immunology|August 25, 2022
Editorial: Novel treatments for diffuse large B-cell lymphoma: The post-CART eraAlberto Mussetti, Enrico Derenzini, Sarkozy Clementine, et al.
Blood|December 8, 2009
Allogeneic transplantation for children and adolescents with Hodgkin lymphomaNorbert Schmitz, Anna Sureda, Giorgio Dini, et al.
Haematologica|November 21, 2007
Allogeneic transplantation in lymphoma: current statusNorbert Schmitz, Peter Dreger, Bertram Glass, et al.
Leukemia & Lymphoma|May 13, 2022
Novel strategies for relapsed/refractory DLBCL; navigating the immunotherapy era in aggressive lymphomaMax J Gordon, Anna Sureda, Jason R Westin
Journal of Clinical Medicine|August 27, 2021
Is Post-Transplant Cyclophosphamide the New Methotrexate?Alberto Mussetti, Annalisa Paviglianiti, Rocio Parody, et al.
Pageof 38